The fact that AQP9 providesAPL cancer cell specificity with high response rates suggests that if arsenic-containingcompounds could be targeted for specific delivery into cancer cells, then theywould represent outstanding agents for killing these cells. This evidence concerns the gene AQP9 and cancer.